Vitamin D receptor activator and dietary sodium restriction to reduce residual urinary albumin excretion in chronic kidney disease (ViRTUE study): rationale and study protocol

Charlotte A. Keyzer; Maarten A. de Jong; G. Fenna van Breda; Marc G. Vervloet; Gozewijn D. Laverman; Marc Hemmelder; Wilbert M. Janssen; Hiddo J. Lambers Heerspink; Gerjan Navis; Martin H. de Borst

doi:https://doi.org/10.1093/ndt/gfv033

Vitamin D receptor activator and dietary sodium restriction to reduce residual urinary albumin excretion in chronic kidney disease (ViRTUE study): rationale and study protocol

Charlotte A. Keyzer, Maarten A. de Jong, G. Fenna van Breda, Marc G. Vervloet, Gozewijn D. Laverman, Marc Hemmelder, Wilbert M. Janssen, Hiddo J. Lambers Heerspink, Gerjan Navis, Martin H. de Borst

Nephrology (VUmc)

Research output: Contribution to journal › Article › Professional

8 Citations (Scopus)

Original language	English
Pages (from-to)	1081-1087
Journal	Nephrology, dialysis, transplantation
Volume	31
Issue number	7
DOIs	https://doi.org/10.1093/ndt/gfv033
Publication status	Published - Jul 2016

Keywords

albuminuria
paricalcitol
randomized-controlled trial
sodium reduction

Access to Document

https://doi.org/10.1093/ndt/gfv033

Cite this

Keyzer, C. A., de Jong, M. A., van Breda, G. F., Vervloet, M. G., Laverman, G. D., Hemmelder, M., Janssen, W. M., Heerspink, H. J. L., Navis, G., & de Borst, M. H. (2016). Vitamin D receptor activator and dietary sodium restriction to reduce residual urinary albumin excretion in chronic kidney disease (ViRTUE study): rationale and study protocol. Nephrology, dialysis, transplantation, 31(7), 1081-1087. https://doi.org/10.1093/ndt/gfv033

@article{c4750abd6b684dd8a534b990cd81b595,

title = "Vitamin D receptor activator and dietary sodium restriction to reduce residual urinary albumin excretion in chronic kidney disease (ViRTUE study): rationale and study protocol",

keywords = "albuminuria, paricalcitol, randomized-controlled trial, sodium reduction",

author = "Keyzer, {Charlotte A.} and {de Jong}, {Maarten A.} and {van Breda}, {G. Fenna} and Vervloet, {Marc G.} and Laverman, {Gozewijn D.} and Marc Hemmelder and Janssen, {Wilbert M.} and Heerspink, {Hiddo J. Lambers} and Gerjan Navis and {de Borst}, {Martin H.}",

year = "2016",

month = jul,

doi = "https://doi.org/10.1093/ndt/gfv033",

language = "English",

volume = "31",

pages = "1081--1087",

journal = "Nephrology, dialysis, transplantation",

issn = "0931-0509",

publisher = "Oxford University Press",

number = "7",

}

Keyzer, CA, de Jong, MA, van Breda, GF , Vervloet, MG, Laverman, GD, Hemmelder, M, Janssen, WM, Heerspink, HJL, Navis, G & de Borst, MH 2016, 'Vitamin D receptor activator and dietary sodium restriction to reduce residual urinary albumin excretion in chronic kidney disease (ViRTUE study): rationale and study protocol', Nephrology, dialysis, transplantation, vol. 31, no. 7, pp. 1081-1087. https://doi.org/10.1093/ndt/gfv033

Vitamin D receptor activator and dietary sodium restriction to reduce residual urinary albumin excretion in chronic kidney disease (ViRTUE study): rationale and study protocol. / Keyzer, Charlotte A.; de Jong, Maarten A.; van Breda, G. Fenna et al.
In: Nephrology, dialysis, transplantation, Vol. 31, No. 7, 07.2016, p. 1081-1087.

Research output: Contribution to journal › Article › Professional

TY - JOUR

T1 - Vitamin D receptor activator and dietary sodium restriction to reduce residual urinary albumin excretion in chronic kidney disease (ViRTUE study): rationale and study protocol

AU - Keyzer, Charlotte A.

AU - de Jong, Maarten A.

AU - van Breda, G. Fenna

AU - Vervloet, Marc G.

AU - Laverman, Gozewijn D.

AU - Hemmelder, Marc

AU - Janssen, Wilbert M.

AU - Heerspink, Hiddo J. Lambers

AU - Navis, Gerjan

AU - de Borst, Martin H.

PY - 2016/7

Y1 - 2016/7

KW - albuminuria

KW - paricalcitol

KW - randomized-controlled trial

KW - sodium reduction

U2 - https://doi.org/10.1093/ndt/gfv033

DO - https://doi.org/10.1093/ndt/gfv033

M3 - Article

C2 - 25744274

SN - 0931-0509

VL - 31

SP - 1081

EP - 1087

JO - Nephrology, dialysis, transplantation

JF - Nephrology, dialysis, transplantation

IS - 7

ER -